Search

Showing total 369 results

Search Constraints

Start Over You searched for: Topic immune system Remove constraint Topic: immune system Publisher wiley Remove constraint Publisher: wiley
369 results

Search Results

1. State‐of‐the‐art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI)

2. Myron Gordon Award paper: Microbes, T‐cell diversity and pigmentation

3. EAACI position paper: Influence of dietary fatty acids on asthma, food allergy, and atopic dermatitis

4. AllergoOncology - the impact of allergy in oncology: EAACI position paper

5. research paper: IL1RN VNTR and IL2−330 polymorphic genes are independently associated with chronic immune thrombocytopenia

6. Informational Paper: Modulation of the Host Response in Periodontal Therapy

7. Serological SARS‐CoV‐2 antibody response, potential predictive markers and safety of BNT162b2 mRNA COVID‐19 vaccine in haematological and oncological patients

8. Development and immunobiological evaluation of nanoparticles containing an immunodominant epitope of herpes simplex virus

9. Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) induces neutralising antibody and polyfunctional T‐cell responses in patients with chronic myeloid leukaemia

10. DISCUSSION PAPER: THE USE OF GLUTARALDEHYDE FIXATION FOR THE STUDY OF THE IMMUNE RESPONSE TO SYNGENEIC TUMOR ANTIGEN

11. Short Paper Sessions

12. DISCUSSION PAPER: IMPAIRMENT OF B-LYMPHOCYTE FUNCTIONS IN CONCANAVALIN A-TREATED FRIEND VIRUS INFECTED MICE

13. Loss ofBAP1expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development

14. Short Papers

15. Phase II trial of single‐agent panobinostat consolidation improves responses after sub‐optimal transplant outcomes in multiple myeloma

16. Neuroprotection induced by dexpramipexole delays disease progression in a mouse model of progressive multiple sclerosis

17. Critical role of OX40 in drug‐induced acute liver injury

18. Changes to the gut microbiota induced by losartan contributes to its antihypertensive effects

19. The enhanced immunopharmacology of VIB4920, a novel Tn3 fusion protein and CD40L antagonist, and assessment of its safety profile in cynomolgus monkeys

20. circFAT1 Promotes Cancer Stemness and Immune Evasion by Promoting STAT3 Activation

21. Steroids Enable Mesenchymal Stromal Cells to Promote CD8+ T Cell Proliferation Via VEGF‐C

22. Not an immune cell, but they may act like one-cells with immune properties outside the immune system.

23. STAT3/NF-kappa B signalling disruption in M2 tumour-associated macrophages is a major target of PLGA nanocarriers/PD-L1 antibody immunomodulatory therapy in breast cancer

24. Regulating Glucose Metabolism with Prodrug Nanoparticles for Promoting Photoimmunotherapy of Pancreatic Cancer

25. Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyond

26. Biomimetic Human Disease Model of SARS‐CoV‐2‐Induced Lung Injury and Immune Responses on Organ Chip System

27. Back to the basics: Propolis and COVID ‐19

28. Metformin Restores Tetracyclines Susceptibility against Multidrug Resistant Bacteria

29. Perturbed Microbial Ecology in Myasthenia Gravis: Evidence from the Gut Microbiome and Fecal Metabolome

30. Supramolecular Prodrug Nanovectors for Active Tumor Targeting and Combination Immunotherapy of Colorectal Cancer

31. Phytophthora infestans RXLR effector SFI5 requires association with calmodulin for PTI/MTI suppressing activity

32. Ectopic cervical thymi and no thymic involution until midlife in naked mole rats

33. Inhibitors of class I histone deacetylases attenuate thioacetamide‐induced liver fibrosis in mice by suppressing hepatic type 2 inflammation

34. DISCUSSION PAPER: HUMORAL IMMUNE RESPONSES TO TUMOR-ASSOCIATED ANTIGENS

35. A pH-sensitive Macromolecular Prodrug as TLR7/8 Targeting Immune Response Modifier

36. Quantitative analysis of the tomato nuclear proteome during Phytophthora capsici infection unveils regulators of immunity

37. Intrinsically altered lung‐resident γδT cells control lung melanoma by producing interleukin‐17A in the elderly

38. Compromised steady‐state germinal center activity with age in nonhuman primates

39. Transcription‐Related Dynamics from Immune Disability into Endogenous Innovation

40. PI3Kgamma Inhibitor Attenuates Immunosuppressive Effect of Poly(l‐Glutamic Acid)‐Combretastatin A4 Conjugate in Metastatic Breast Cancer

41. Fasciola hepatica products can alter the response of bovine immune cells to Mycobacterium avium subsp. paratuberculosis

42. HIV, HCMV and mycobacterial antibody levels: a cross-sectional study in a rural Ugandan cohort

43. Immunogenic Cell Death Inducing Fluorinated Mitochondria‐Disrupting Helical Polypeptide Synergizes with PD‐L1 Immune Checkpoint Blockade

44. Mitochondrial Damage‐Induced Innate Immune Activation in Vascular Smooth Muscle Cells Promotes Chronic Kidney Disease‐Associated Plaque Vulnerability

45. Biomimetic Anti‐PD‐1 Peptide‐Loaded 2D FePSe 3 Nanosheets for Efficient Photothermal and Enhanced Immune Therapy with Multimodal MR/PA/Thermal Imaging

46. Penetrable Nanoplatform for 'Cold' Tumor Immune Microenvironment Reeducation

47. Functionality testing of stem cell grafts to predict infectious complications after allogeneic hematopoietic stem cell transplantation

48. Targeting and Specific Activation of Antigen‐Presenting Cells by Endogenous Antigen‐Loaded Nanoparticles Elicits Tumor‐Specific Immunity

49. Multifunctional Nanoregulator Reshapes Immune Microenvironment and Enhances Immune Memory for Tumor Immunotherapy

50. Viromimetic STING Agonist‐Loaded Hollow Polymeric Nanoparticles for Safe and Effective Vaccination against Middle East Respiratory Syndrome Coronavirus